Why Quality Matters in AAV Gene Therapy Development
An overview of why product characterization, analytical methods, manufacturing consistency, and potency assessment matter in AAV gene therapy development.
An overview of why product characterization, analytical methods, manufacturing consistency, and potency assessment matter in AAV gene therapy development.
Newborn screening offers a critical opportunity to identify rare genetic diseases early and enable timely interventions, including gene therapy for conditions such as SMA.